Search research articles
Contact Us
Filters
Showing results (51-60 of 113) with videos related to
Page
of 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2011
Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary
Gauri R Varadhachary, Yael Spector, James L Abbruzzese, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
April 18, 2014
Does IGFR1 inhibition result in increased muscle mass loss in patients undergoing treatment for pancreatic cancer?
David R Fogelman, Holly Holmes, Khalil Mohammed, et al.
Investigational New Drugs
|
January 29, 2010
A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancer
Bassel Fuad El-Rayes, Philip A Philip, Fazlul H Sarkar, et al.
Cancer Medicine
|
June 11, 2020
Modified gemcitabine plus nab-paclitaxel regimen in advanced pancreatic ductal adenocarcinoma
Jane E Rogers, Jonathan D Mizrahi, Lianchun Xiao, et al.
Journal of the American College of Surgeons
|
February 28, 2007
Delayed recovery after pancreaticoduodenectomy: a major factor impairing the delivery of adjuvant therapy?
Thomas A Aloia, Thomas E Aloia, Jeffrey E Lee, et al.
Annals of Diagnostic Pathology
|
November 5, 2011
Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis
Qing Zhao, Asif Rashid, Yun Gong, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
January 15, 2020
Modified FOLFIRINOX in pancreatic cancer patients Age 75 or older
Jonathan D Mizrahi, Jane E Rogers, Kenneth R Hess, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
October 17, 2013
Morbidity and mortality after pancreaticoduodenectomy in patients with borderline resectable type C clinical classification
Ching-Wei D Tzeng, Matthew H G Katz, Jason B Fleming, et al.
Histopathology
|
May 7, 2015
The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomy
Laurice K Fischer, Matthew H Katz, Sun M Lee, et al.
Annals of Surgical Oncology
|
February 15, 2013
Frequency and intensity of postoperative surveillance after curative treatment of pancreatic cancer: a cost-effectiveness analysis
Ching-Wei D Tzeng, Daniel E Abbott, Scott B Cantor, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 113) with videos related to
Sort By:
Page
of 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2011
Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary
Gauri R Varadhachary, Yael Spector, James L Abbruzzese, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
April 18, 2014
Does IGFR1 inhibition result in increased muscle mass loss in patients undergoing treatment for pancreatic cancer?
David R Fogelman, Holly Holmes, Khalil Mohammed, et al.
Investigational New Drugs
|
January 29, 2010
A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancer
Bassel Fuad El-Rayes, Philip A Philip, Fazlul H Sarkar, et al.
Cancer Medicine
|
June 11, 2020
Modified gemcitabine plus nab-paclitaxel regimen in advanced pancreatic ductal adenocarcinoma
Jane E Rogers, Jonathan D Mizrahi, Lianchun Xiao, et al.
Journal of the American College of Surgeons
|
February 28, 2007
Delayed recovery after pancreaticoduodenectomy: a major factor impairing the delivery of adjuvant therapy?
Thomas A Aloia, Thomas E Aloia, Jeffrey E Lee, et al.
Annals of Diagnostic Pathology
|
November 5, 2011
Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis
Qing Zhao, Asif Rashid, Yun Gong, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
January 15, 2020
Modified FOLFIRINOX in pancreatic cancer patients Age 75 or older
Jonathan D Mizrahi, Jane E Rogers, Kenneth R Hess, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
October 17, 2013
Morbidity and mortality after pancreaticoduodenectomy in patients with borderline resectable type C clinical classification
Ching-Wei D Tzeng, Matthew H G Katz, Jason B Fleming, et al.
Histopathology
|
May 7, 2015
The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomy
Laurice K Fischer, Matthew H Katz, Sun M Lee, et al.
Annals of Surgical Oncology
|
February 15, 2013
Frequency and intensity of postoperative surveillance after curative treatment of pancreatic cancer: a cost-effectiveness analysis
Ching-Wei D Tzeng, Daniel E Abbott, Scott B Cantor, et al.
Page
of 12